Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.02 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |